Senna-S

Docusate Sodium 50 mg Sennosides 8.6 mg · SENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1 · Tablet, Film Coated · Oral · Aarkish Pharmaceuticals NJ Inc.

NDC 81005-0102-30 · 300 TABLET, FILM COATED in 1 BOTTLE, PLASTIC · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Not scored — fragility is computed for NADAC-priced NDCs.

0.1%chance of a new FDA shortage posting for docusate sodium 50 mg and sennosides 8.6 mg (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

No FDA shortage reports for this drug or its presentations.

No enforcement reports list this package NDC.

Labeler	Strength	First seen	Last seen
Aarkish Pharmaceuticals NJ Inc.	SENNOSIDES 8.6 mg/1; DOCUSATE SODIUM 50 mg/1	Aug 26, 2026	Sep 2, 2026
Aarkish Pharmaceuticals NJ Inc.	SENNOSIDES 50 mg/1; DOCUSATE SODIUM 8.6 mg/1	Jul 29, 2026	Aug 19, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

DrugDashboards, "Senna-S — NDC 81005-0102-30," retrieved September 3, 2026, https://drugdashboards.com/drug/81005010230.

Free to cite with attribution — see how the data is put together.